March 11 (Reuters) - A federal judge has ruled in favor
of Merck ( MRK ) in litigation accusing the drugmaker of
concealing the risks of Gardasin, a vaccine to prevent cervical
and other fatal cancers.
The decision was made public on Tuesday by U.S. District
Judge Kenneth Bell in Charlotte, North Carolina.
(Reporting by Jonathan Stempel in New York)